858677-99-3

Basic information

• Product Name: Benzenamine, 4-[2-(diethylamino)ethoxy]-N-methyl-
• CAS NO: 858677-99-3
• Molecular Formula: C13H22N2O
• Molecular Weight: 222.33
• Mol File: 858677-99-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzenamine, 4-[2-(diethylamino)ethoxy]-N-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 4-[2-(diethylamino)ethoxy]-N-methyl-(858677-99-3)
• EPA Substance Registry System: Benzenamine, 4-[2-(diethylamino)ethoxy]-N-methyl-(858677-99-3)

Safety Data

• Hazardous Substances Data: 858677-99-3(Hazardous Substances Data)

Upstream product

• 579-58-8 N-methyl-(4-acetamido)phenol 
• 100-35-6 2-(diethylamino)ethyl chloride 

Relevant articles and documents

BETA-KETOAMIDE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING SAID COMPOUNDS

The invention relates to β-ketoamide compounds of general formula (I) wherein the groups and radicals A, B, b, X, Y, Z, R1, R2, R3, R5a and R5b have the designations cited in patent claim 1. The invention also relates to medicaments containing at least one inventive amide. As a result of the MCH receptor antagonistic activity, the inventive medicaments are suitable for treating metabolic disorders and/or eating disorders, especially adipositas, bulimia, anorexia, hyperphagia and diabetes.

3-(4-PIPERIDINE-1YLMETHYL-PHENYL)-PROPION ACID-PHENYLAMIDE-DERIVATIVES AND RELATED COMPOUNDS USED IN THE FORM OF MCH ANTAGONISTS (MELANINE CONCENTRATING HORMONE) FOR TREATING EATING DISORDERS

The invention relates to amid compounds of general formula (I), wherein groups and residuals A, B, b, W, X, Y, Z, R1, R2 and R3 have significances given in a claim 1. In addition, said invention relates to drugs containing at least one type of inventive amid. Because of the antagonist activity of an MCH-receptor, the inventive drugs are suitable for treating metabolic disturbances and/or eating disorders, in particular adiposity, bulimia, anorexia, hyperphagia and diabetes.